Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival

被引:7
作者
Arthur, Anna E. [1 ,2 ]
Bellile, Emily L. [3 ,4 ]
Rozek, Laura S. [2 ,5 ]
Peterson, Karen E. [2 ,6 ]
Ren, Jianwei [7 ]
Harris, Ethan [7 ]
Mueller, Christie [7 ]
Jolly, Shruti [8 ]
Peterson, Lisa A. [5 ]
Wolf, Gregory T. [5 ]
Djuric, Zora [2 ,7 ]
机构
[1] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA
[2] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Ctr Canc Biostat, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[7] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[8] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2016年 / 38卷
基金
美国国家卫生研究院;
关键词
serum micronutrients; xanthophylls; quercetin; head and neck cancer; recurrence; survival; SQUAMOUS-CELL CARCINOMA; PAPILLOMAVIRUS-POSITIVE HEAD; PLASMA CAROTENOIDS; RADIATION-THERAPY; DIETARY PATTERNS; LUNG-CANCER; QUERCETIN; FRUIT; RISK; FLAVONOIDS;
D O I
10.1002/hed.24283
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to examine associations of pretreatment serum carotenoids, tocopherols, and quercetin with prognosis in 154 patients newly diagnosed with head and neck cancer. Methods. Pretreatment blood and health surveys were collected. Serum micronutrients were measured by high performance liquid chromatography. Data on recurrence and death were collected annually. Cox proportional hazards models measured associations of serum nutrient concentrations with recurrence and overall survival. Results. During a median follow-up time of 37 months, there were 32 recurrences and 27 deaths. After controlling for covariates, subjects with high versus low serum xanthophyll and total carotenoid concentrations had significantly longer recurrence-free time (p = .002 and p = .02, respectively). Overall survival time was significantly longer in patients with high versus low serum xanthophyll concentrations (p = .02). Conclusion. Future research should evaluate the possible benefits of interventions to increase intakes of rich food sources of xanthophylls in this patient population. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:E1591 / E1597
页数:7
相关论文
共 50 条
[41]   Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium [J].
Leoncini, Emanuele ;
Vukovic, Vladimir ;
Cadoni, Gabriella ;
Giraldi, Luca ;
Pastorino, Roberta ;
Arzani, Dario ;
Petrelli, Livia ;
Wunsch-Filho, Victor ;
Toporcov, Tatiana Natasha ;
Moyses, Raquel Ayub ;
Matsuo, Keitaro ;
Bosetti, Cristina ;
La Vecchia, Carlo ;
Serraino, Diego ;
Simonato, Lorenzo ;
Merletti, Franco ;
Boffetta, Paolo ;
Hashibe, Mia ;
Lee, Yuan-Chin Amy ;
Boccia, Stefania .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2018, 33 (12) :1205-1218
[42]   PRETREATMENT FDG-PET STANDARDIZED UPTAKE VALUE AS A PROGNOSTIC FACTOR FOR OUTCOME IN HEAD AND NECK CANCER [J].
Machtay, Mitchell ;
Natwa, Mona ;
Andrei, Jocelyn ;
Hyslop, Terry ;
Anne, P. Rani ;
Lavarino, Jororsali ;
Intenzo, Charles M. ;
Keane, William .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (02) :195-201
[43]   Efficacy of Neck Dissection in the Management of Isolated Nodal Recurrence after Head and Neck Cancer Treatment [J].
Chan, Jimmy Yu-wai .
CURRENT ONCOLOGY REPORTS, 2013, 15 (02) :142-145
[44]   Effect of socioeconomic status on survival in patients with head and neck cancer [J].
Weizman, Baruch ;
Golan, Nili ;
Ronen, Ohad .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (10) :3001-3009
[45]   High serum carbonic anhydrase IX predicts shorter survival in head and neck cancer [J].
Rosenberg, V ;
Pastorekova, S. ;
Zatovicova, M. ;
Vidlickova, I ;
Jelenska, L. ;
Slezak, P. .
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (04) :201-204
[46]   Survival Trends in Head and Neck Cancer: Opportunities for Improving Outcomes [J].
Rodriguez, Cristina P. ;
Adelstein, David J. .
ONCOLOGIST, 2010, 15 (09) :921-923
[47]   Pretreatment body mass index and head and neck cancer outcome: A review of the literature [J].
den Hollander, Dide ;
Kampman, Ellen ;
van Herpen, Carla M. L. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (02) :328-338
[48]   Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival [J].
Peters, Thomas T. ;
Senft, Asaf ;
Hoekstra, Otto S. ;
Castelijns, J. A. ;
Witte, Birgit I. ;
Leemans, C. Rene ;
de Bree, Remco .
ORAL ONCOLOGY, 2015, 51 (03) :267-271
[49]   Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients [J].
Teft, Wendy A. ;
Winquist, Eric ;
Nichols, Anthony C. ;
Kuruvilla, Sara ;
Richter, Suzanne ;
Parker, Christina ;
Francis, Peggy ;
Trinnear, Maureen ;
Lukovic, Jelena ;
Bukhari, Nedal ;
Choi, Yun-Hee ;
Welch, Stephen ;
Palma, David A. ;
Yoo, John ;
Kim, Richard B. .
ORAL ONCOLOGY, 2019, 89 :72-78
[50]   Single nucleotide polymorphisms in nucleotide excision repair genes, cancer treatment, and head and neck cancer survival [J].
Wyss, Annah B. ;
Weissler, Mark C. ;
Avery, Christy L. ;
Herring, Amy H. ;
Bensen, Jeannette T. ;
Barnholtz-Sloan, Jill S. ;
Funkhouser, William K. ;
Olshan, Andrew F. .
CANCER CAUSES & CONTROL, 2014, 25 (04) :437-450